|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2004-6-16
|
|
pubmed:abstractText |
We propose a simple modification to an established blood-brain barrier disruption (BBBD) animal model that allows us to use ketamine/xylazine as the anaesthetic agent, therefore decreasing the complexity and the cost of the model, while maintaining similar efficiency.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0317-1671
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
31
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
248-53
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15198452-Adrenergic alpha-Agonists,
pubmed-meshheading:15198452-Anesthetics, Dissociative,
pubmed-meshheading:15198452-Animals,
pubmed-meshheading:15198452-Blood-Brain Barrier,
pubmed-meshheading:15198452-Cerebrovascular Circulation,
pubmed-meshheading:15198452-Diuretics, Osmotic,
pubmed-meshheading:15198452-Female,
pubmed-meshheading:15198452-Hemodynamics,
pubmed-meshheading:15198452-Ketamine,
pubmed-meshheading:15198452-Mannitol,
pubmed-meshheading:15198452-Models, Animal,
pubmed-meshheading:15198452-Rats,
pubmed-meshheading:15198452-Rats, Long-Evans,
pubmed-meshheading:15198452-Xylazine
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
A blood-brain barrier disruption model eliminating the hemodynamic effect of ketamine.
|
|
pubmed:affiliation |
Department of Neurosurgery, University of Sherbrooke Hospital, Sherbrooke, Quebec, Canada.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
